Evidence map›Paper›PMID 31084022›Full record

ArticleJournal of the American Chemical Society2019

Enabling Two-Electron Pathways with Iron and Cobalt: From Ligand Design to Catalytic Applications.

Rebeca Arevalo, Paul J Chirik

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Cobalt-Catalyzed Intramolecular C─H Silylation of Arenes.Angewandte Chemie (International ed. in English) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Iron-CatalyzedJournal of the American Chemical Society · 2023
    Article
  8. Review
  9. Article
  10. C(spACS catalysis · 2022
    Article
  11. Article
  12. Cooperative C-H Bond Activation by a Low-Spin dJournal of the American Chemical Society · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Iron(II) Complexes Featuring a Redox-Active Dihydrazonopyrrole Ligand.Zeitschrift fur anorganische und allgemeine Chemie · 2021
    Article
  17. Catalytic hydrogenation enabled by ligand-based storage of hydrogen.Chemical communications (Cambridge, England) · 2021
    Article
  18. Article
  19. Iron Catalyzed Double Bond Isomerization: Evidence for an FeChemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rebeca ArevaloDepartment of Chemistry , Princeton University , Princeton , New Jersey 08544 , United States.ORCID 0000-0003-1643-4607
Paul J ChirikDepartment of Chemistry , Princeton University , Princeton , New Jersey 08544 , United States.ORCID 0000-0001-8473-2898

Funding

Earth abundant catalysts as an enabling tool for organic synthesisR01GM121441 · NIGMS · PRINCETON UNIVERSITY · PI CHIRIK, PAUL J · 2017 to 2025
$2.5M
NIGMS NIH HHS R01 GM121441
6 · The paper itself

Abstract

Homogeneous catalysis with Earth-abundant, first-row transition metals, including iron and cobalt, has gained considerable recent attention as a potentially cost-effective and sustainable alternative to more commonly and historically used precious metals. Because fundamental organometallic transformations, such as oxidative addition and reductive elimination, are two-electron processes and essential steps in many important catalytic cycles, controlling redox chemistry-in particular overcoming one-electron chemistry-has been as a central challenge with Earth-abundant metals. This Perspective focuses on approaches to impart sufficiently strong ligand fields to generate electron-rich metal complexes able to promote oxidative addition reactions where the redox changes are exclusively metal-based. Emphasis is placed on how ligand design and exploration of fundamental organometallic chemistry coupled with mechanistic understanding have been used to discover iron catalysts for the hydrogen isotope exchange in pharmaceuticals and cobalt catalysts for C(sp

Indexed as

CatalysisCobaltHydrocarbons, CyclicIronLigandsMolecular StructureOxidation-ReductionPharmaceutical PreparationsCobaltHydrocarbons, CyclicIronLigandsPharmaceutical Preparations

Identifiers

PMID31084022
PMCPMC6561843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.